• 1
    Firestein GS, Zvaifler NJ: How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33: 768773, 1990
  • 2
    Arend WP, Dayer J-M: Cytokine and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33: 305315, 1990
  • 3
    Alvaro-Gracia JM, Zvaifler NJ, Firestein GS: Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 86: 17901798, 1990
  • 4
    Chandrasekhar S, Harvey AK, Hrubey PS, Bendele AM: Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injection. Clin Immunol Immunopathol 55: 382394, 1990
  • 5
    Henderson B, Pettipher ER: Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 75: 306310, 1989
  • 6
    Wahl SM, Allen JB, Wong HL, Dougherty SF, Ellingsworth LR: Antagonistic and agonistic effects of transforming growth factor-beta and IL-1 in rheumatoid synovium. J Immunol 145: 25142519, 1990
  • 7
    Arend WP, Joslin JG, Massoni RJ: Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J Immunol 134: 38683875, 1985
  • 8
    Balavoine J-F, deRochemontiex B, Williamson K, Seckinger P, Cruchaud A, Dayer J-M: Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). J Clin Invest 78: 11201124, 1986
  • 9
    Dripps DJ, Verderber E, Ng RK, Thompson RC, Eisenberg SP: Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils. J Biol Chem 266: 2031120315, 1991
  • 10
    Arend WP, Welgus HG, Thompson RC, Eisenberg SP: Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 85: 16941697, 1990
  • 11
    Carter DB, Deibel MR Jr, Dunn CJ, Tomich CS, Laborde AL, Slightom JL, Berger AE, Bienkowski MJ, Sun FF, McEwan RN: Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 344: 633638, 1990
  • 12
    Arend WP: Interleukin 1 receptor antagonist: a new member of the interleukin 1 family. J Clin Invest 88: 14451451, 1991
  • 13
    Eisenberg SP, Evans RJ, Arend WP, Verderber E, Brewer MT, Hannum CH, Thompson RC: Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 343: 341346, 1990
  • 14
    Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC: Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343: 336340, 1990
  • 15
    Bigler CF, Norris DA, Weston WL, Arend WP: Interleukin-1 receptor antagonist production by human keratinocytes. J Invest Dermatol 98: 3844, 1992
  • 16
    Haskill S, Martin G, Van Le L, Morris J, Peace A, Biegler CF, Jaffe GJ, Hammerberg C, Sporn SA, Fong S, Arend WP, Ralph P: cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium. Proc Natl Acad Sci U S A 88: 36813685, 1991
  • 17
    Chan LS, Hammerberg C, Kang K, Sabb P, Tavakkol A, Cooper KD: Human dermal fibroblast interleukin-1 receptor antagonist (IL-1ra) and interleukin-1 beta (IL-1 beta) mRNA and protein are co-stimulated by phorbol ester: implication for a homeostatic mechanism. J Invest Dermatol 99: 315322, 1992
  • 18
    Quay J, Arend WP, Becker S: IL-1 and IL-1 receptor antagonist production in human alveolar macrophages infected with respiratory syncytial virus. J Infect Dis (in press)
  • 19
    Miossec P, Dinarello CA, Ziff M: Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum 29: 461470, 1986
  • 20
    Symons JA, McDowell TL, di Giovine FS, Wood NC, Capper SJ, Duff GW: Interleukin 1 in rheumatoid arthritis: potentiation of immune responses within the joint. Lymphokine Res 8: 365372, 1989
  • 21
    Rooney M, Symons JA, Duff GW: Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis. Rheumatol Int 10: 217219, 1990
  • 22
    Firestein GS, Berger AE, Tracey DE, Chosay JG, Chapman DL, Paine MM, Yu C, Zvaifler NJ: IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 149: 10541062, 1992
  • 23
    Koch AE, Kunkel SL, Chensue SW, Haines GK, Strieter RM: Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages. Clin Immunol Immunopathol 65: 2327, 1992
  • 24
    Deleuran BW, Chu CQ, Field M, Brennan FM, Katsikis P, Feldmann M, Maini RN: Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis. Br J Rheumatol 31: 801809, 1992
  • 25
    Malyak M, Swaney RE, Arend WP: Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies: potential contribution from synovial fluid neutrophils. Arthritis Rheum 36: 781789, 1993
  • 26
    Firestein GS, Alvaro-Gracia JM, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 144: 33473353, 1990
  • 27
    Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M: Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha. Clin Exp Immunol 73: 449455, 1988
  • 28
    Malyak M, Joslin FG, Verderber EL, Eisenberg SP, Arend WP: IL-1ra ELISA: reduction and alkylation of synovial fluid eliminates interference by IgM rheumatoid factors. J Immunol Methods 140: 281288, 1991
  • 29
    Herzyk DJ, Berger AE, Allen JN, Wewers MD: Sandwich ELISA formats designed to detect 17 kDa IL-1 beta significantly underestimate 35 kDa IL-1 beta. J Immunol Methods 148: 243254, 1992
  • 30
    Tsai V, Firestein GS, Arend W, Zvaifler NJ: Cytokine-induced differentiation of cultured nonadherent macrophages. Cell Immunol 144: 203216, 1992
  • 31
    Moore SA, Strieter RM, Rolfe MW, Standiford TJ, Burdick MD, Kunkel SL: Expression and regulation of human alveolar macrophage-derived interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 6: 569575, 1992
  • 32
    Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP: Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 266: 1033110336, 1991
  • 33
    Arend WP, Coll BP: Interaction of recombinant monocyte-derived interleukin 1 receptor antagonist with rheumatoid synovial cells. Cytokine 3: 407413, 1991
  • 34
    Smith RJ, Chin JE, Sam LM, Justen JM: Biologic effects of an interleukin-1 receptor antagonist protein on interleukin-1–stimulated cartilage erosion and chondrocyte responsiveness. Arthritis Rheum 34: 7883, 1991
  • 35
    Seckinger P, Klein-Nulend J, Alander C, Thompson RC, Dayer JM, Raisz LG: Natural and recombinant human IL-1 receptor antagonists block the effects of IL-1 on bone resorption and prostaglandin production. J Immunol 145: 41814184, 1990
  • 36
    Mosley B, Urdal DL, Prickett KS, Larsen A, Cosman D, Conlon PJ, Gillis S, Dower SK: The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor. J Biol Chem 262: 29412944, 1987
  • 37
    Fujii I, Shingu M, Nobunaga M: Monocyte activation in early onset rheumatoid arthritis. Ann Rheum Dis 49: 497503, 1990
  • 38
    Krzesicki RF, Hatfield CA, Bienkowski MJ, McGuire JC, Winterrowd GE, Chapman DL, Berger AE, McEwan RN, Carter DB, Chosay JG, Tracey DE, Chin JE: Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts. J Immunol 150: 40084018, 1993
  • 39
    Alvaro-Gracia JM, Zvaifler NJ, Brown CB, Kaushansky K, Firestein GS: Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocytemacrophage colony-stimulating factor production and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor necrosis factor-alpha. J Immunol 146: 33653371, 1991
  • 40
    Janson RW, Hance KR, Arend WP: Production of IL-1 receptor antagonist by human in vitro-derived macrophages: effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor. J Immunol 147: 42184223, 1991
  • 41
    Hogg N, Palmer DG, Revell PA: Mononuclear phagocytes of normal and rheumatoid synovial membrane identified by monoclonal antibodies. Immunology 56: 673681, 1985
  • 42
    O'Garra A, Vieira P: Polymerase chain reaction for detection of cytokine gene expression. Curr Opin Immunol 4: 211215, 1992
  • 43
    Hogquist KA, Nett MA, Unanue ER, Chaplin DD: Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci U S A 88: 84858489, 1991
  • 44
    Miller LC, Lynch EA, Isa S, Logan JW, Dinarello CD, Steere AC: Balance of synovial fluid 1L-1β and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 341: 146148, 1993
  • 45
    Malyak M, Smith MF Jr, Abel AA, Arend WP: Peripheral blood neutrophil production of interleukin-1β and interleukin-1 receptor antagonist. J Clin Immunol 14: 2030, 1994
  • 46
    Bertini R, Sironi M, Martin-Padura I, Colotta F, Rambaldi S, Bernasconi S, Ghezzi P, Haskill SJ, Liu D, Mantovani A: Inhibitory effect of recombinant intracellular interleukin 1 receptor antagonist on endothelial cell activation. Cytokine 4: 4447, 1992